Skip Nav Destination
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion
Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL
Plasma hepcidin is associated with future risk of venous thromboembolism
Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
Issue Archive
June 12 2018
In this Issue
Table of Contents
EXCEPTIONAL CASE REPORTS
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
Clinical Trials & Observations
Anne Sophie Kubasch,Rebekka Wehner,Serena Bazzurri,Antje Tunger,Sebastian Stasik,Marlene Garzarolli,Jörn Meinel,Gustavo Baretton,Friedegund Meier,Christian Thiede,Marc Schmitz,Uwe Platzbecker
A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion
Clinical Trials & Observations
Christopher A. Miller,Christopher Tricarico,Zachary L. Skidmore,Geoffrey L. Uy,Yi-Shan Lee,Anjum Hassan,Michelle D. O’Laughlin,Heather Schmidt,Ling Tian,Eric J. Duncavage,Malachi Griffith,Obi L. Griffith,John S. Welch,Lukas D. Wartman
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
HEALTH SERVICES AND OUTCOMES
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL
Clinical Trials & Observations
Chelsea C. Pinnix,Andrea K. Ng,Bouthaina S. Dabaja,Sarah A. Milgrom,Jillian R. Gunther,C. David Fuller,Grace L. Smith,Zeinab Abou Yehia,Wei Qiao,Christine F. Wogan,Mani Akhtari,Osama Mawlawi,L. Jeffrey Medeiros,Hubert H. Chuang,William Martin-Doyle,Philippe Armand,Ann S. LaCasce,Yasuhiro Oki,Michelle Fanale,Jason Westin,Sattva Neelapu,Loretta Nastoupil
MYELOID NEOPLASIA
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
Plasma hepcidin is associated with future risk of venous thromboembolism
Clinical Trials & Observations
Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin
Clinical Trials & Observations
Romy M. W. Kremers,Stéphane Zuily,Hilde Kelchtermans,Tessa C. Peters,Saartje Bloemen,Véronique Regnault,H. Coenraad Hemker,Philip G. de Groot,Denis Wahl,Bas de Laat
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Clinical Trials & Observations
Suman L. Sood,Dunlei Cheng,Margaret Ragni,Craig M. Kessler,Doris Quon,Amy D. Shapiro,Nigel S. Key,Marilyn J. Manco-Johnson,Adam Cuker,Christine Kempton,Tzu-Fei Wang,M. Elaine Eyster,Philip Kuriakose,Annette von Drygalski,Joan Cox Gill,Allison Wheeler,Peter Kouides,Miguel A. Escobar,Cindy Leissinger,Sarah Galdzicka,Marshall Corson,Crystal Watson,Barbara A. Konkle
TRANSPLANTATION
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
Clinical Trials & Observations
Tara M. Robinson,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Ephraim J. Fuchs,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Mei-Jie Zhang,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Andrew St. Martin,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Myriam Labopin,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Daniel A. Keesler,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Didier Blaise,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Asad Bashey,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Jean-Henri Bourhis,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Fabio Ciceri,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Stefan O. Ciurea,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Steven M. Devine,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Mohamad Mohty,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Shannon R. McCurdy,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Noel Milpied,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Ian K. McNiece,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Vanderson Rocha,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Rizwan Romee,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Gerard Socie,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Ibrahim Yakoub-Agha,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Robert J. Soiffer,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Mary Eapen,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research,Arnon Nagler,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
Clinical Trials & Observations
Andrew C. Harris,Jaap J. Boelens,Kwang Woo Ahn,Mingwei Fei,Allistair Abraham,Andrew Artz,Christopher Dvorak,Haydar Frangoul,Cesar Freytes,Robert Peter Gale,Sanghee Hong,Hillard M. Lazarus,Alison Loren,Shin Mineishi,Taiga Nishihori,Tracey O’Brien,Kirsten Williams,Marcelo C. Pasquini,John E. Levine
ERRATUM
-
Cover Image
Cover Image
COVER FIGURE
Immunofluorescence image showing murine hematopoietic stem cells (HSCs) stained with keratin 18 (Krt18) antibodies (red) and DAPI (4′,6-diamidino-2-phenylindole; blue). Krt18 is preferentially expressed in HSCs compared with other hematopoietic progenitor cells. See the article by Chapple et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals